⌘K

Login Start Free

Home/Insiders/Schultes Birgit C

SB

SEC Insider//CIK 0002051419

Schultes Birgit C

CIK 00020514191 companyCAMBRIDGE, MA

Transactions

6

Companies

1

Filings

4

CIK

0002051419

Recent Transactions

6 trades

Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2026-03-01+39,200→ 137,733 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2026-03-01+56,000→ 56,000 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2026-01-05$9.21/sh−8,508→ 98,533 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2025-10-01$17.38/sh−31→ 105,184 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2025-03-01+37,600→ 105,215 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2025-03-01+53,714→ 53,714 total

Companies

1

Intellia Therapeutics, Inc.
EVP, Chief Scientific Officer
$NTLA

Recent Filings

4

Address

C/O INTELLIA THERAPEUTICS, INC. 40 ERIE STREET, SUITE 130

CAMBRIDGE, MA, 02139

View on SEC.gov